Home / Knowledge Centre /
Whitepaper

Ensuring Consistency in Polymorphic Drug Substances and Products

To ensure the quality of pharmaceutical products, manufacturers must characterise and quantify their physical nature throughout all phases of development, beginning with the drug substance, or Active Pharmaceutical Ingredients (API), and over the product’s entire shelf life.
Whitepaper key topics: 

  • Ensuring Consistency
  • When and how to apply a specification limit
  • Manufacturing and Transformation of forms
  • Regulatory requirements
  • Establishing and monitoring the presence of Polymorphs
  • How X-Ray powder diffraction works
View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies